"Cutting" by 90%! Great Wall Fund lowers NH HEALTH valuation

Wallstreetcn
2025.06.25 11:26

Great Wall Fund announced that it has lowered the valuation of NH HEALTH to HKD 1.20 per share, which represents a 91.51% decrease compared to the price before the suspension. This is the second time Great Wall Fund has adjusted its valuation of NH HEALTH, following the adjustment to HKD 7.48 per share last July. Industry insiders indicate that since mid-last year, several fund companies have successively adjusted their valuations of NH HEALTH, reflecting the pessimistic expectations of investment institutions regarding its resumption prospects. NH HEALTH has transitioned from being the "first stock for cancer early screening" to a recent valuation close to zero, highlighting the potential compliance risks hidden beneath the high-growth narrative of biotechnology companies. (China Fund News)

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.